TIM
MRNA icon

Tortoise Investment Management’s Moderna MRNA Stock Holding History

Tortoise Investment Management’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-602
Closed -$15.6K – 967
2025
Q3 		$15.6K Hold
602
– – ﹤0.01% 558
2025
Q2 		$16.6K Hold
602
– – ﹤0.01% 539
2025
Q1 		$17.1K Sell
602
-70
-10% -$2.48K ﹤0.01% 528
2024
Q4 		$27.9K Hold
672
– – ﹤0.01% 505
2024
Q3 		$44.9K Sell
672
-1,000
-60% -$91.8K ﹤0.01% 425
2024
Q2 		$199K Hold
1,672
– – 0.02% 206
2024
Q1 		$178K Hold
1,672
– – 0.02% 232
2023
Q4 		$166K Hold
1,672
– – 0.02% 230
2023
Q3 		$173K Buy
1,672
+1,000
+149% +$112K 0.03% 209
2023
Q2 		$81.6K Hold
672
– – 0.01% 300
2023
Q1 		$103K Hold
672
– – 0.02% 264
2022
Q4 		$121K Sell
672
-68
-9% -$11.1K 0.02% 244
2022
Q3 		$88K Hold
740
– – 0.02% 258
2022
Q2 		$106K Sell
740
-10
-1% -$1.43K 0.02% 219
2022
Q1 		$129K Buy
750
+580
+341% +$97.6K 0.02% 214
2021
Q4 		$43K Buy
170
+120
+240% +$35.1K 0.01% 310
2021
Q3 		$19K Buy
50
+20
+67% +$7.38K ﹤0.01% 390
2021
Q2 		$7K Sell
30
-15
-33% -$2.68K ﹤0.01% 498
2021
Q1 		$6K Sell
45
-127
-74% -$18.4K ﹤0.01% 484
2020
Q4 		$18K Buy
+172
New +$17.4K ﹤0.01% 343

Other funds holding MRNA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.68B AUM 19.9% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Tortoise Investment Management's MRNA Position: Q4 2025 in Review

Tortoise Investment Management sold out of Moderna (MRNA) in Q4 2025, closing a stake of 602 shares — an estimated $15.6K sold.

Tortoise Investment Management first reported a position in MRNA in Q4 2020 and held it in 20 quarters. The position peaked at $199K in Q2 2024. 673 funds tracked by Wall St. Rank hold MRNA as of Q4 2025.

  • Tortoise Investment Management reported no remaining Moderna position as of Q4 2025 after selling out during the quarter.
  • Tortoise Investment Management sold 602 Moderna shares in Q4 2025, an estimated $15.6K.
  • Tortoise Investment Management first reported a position in Moderna in Q4 2020 and held it in 20 quarters.
  • Tortoise Investment Management's Moderna position peaked at $199K in Q2 2024.
  • 673 funds tracked by Wall St. Rank held Moderna as of Q4 2025.

Based on Tortoise Investment Management's 13F filing for Q4 2025, filed 6 Feb 2026.